Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.46 B1.5 B1.54 B1.48 B — Research & development ———— — Operating income 668 M707 M509 M-651 M 1.23 B Non-Operating Income, Total 10 M11 M16 M— — Interest expense, net of interest capitalized 80 M88 M101 M74 M — Non-Operating Income, excl. Interest Expenses -80 M-88 M-101 M— — Unusual income/expense 10 M11 M16 M30 M — Pretax income 598 M630 M392 M2.17 B 3.79 B Equity in earnings ———— — Taxes 144 M159 M12 M419 M 734 M Non-controlling/minority interest 4 M4 M19 M4 M — After tax other income/expense ———— — Net income before discontinued operations 450 M467 M399 M1.75 B 3.07 B Discontinued operations ———— — Net income 450 M467 M399 M1.75 B 3.07 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 450 M467 M399 M1.75 B 3.07 B Basic earnings per share (Basic EPS) 1.891.981.690.96 — Diluted earnings per share (Diluted EPS) 1.881.971.697.41 12.95 Average basic shares outstanding 238 M236 M-474 M236 M — Diluted shares outstanding 239 M237 M-476 M237 M — EBITDA 971 M1.03 B699 M— — EBIT 738 M792 M451 M— — Cost of revenue 61.69 B63.23 B58.44 B— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 233 M234 M248 M361 M 1.08 B